Evaluation of abuse and dependence on drugs used for self-medication: A pharmacoepidemiological pilot study based on community pharmacies in France

Drug Safety

Volumn 32, Issue 10, 2009, Pages 859-873

  Orriols, Ludivine ^a   Gaillard, Julia ^a   Lapeyre Mestre, Maryse ^a,b   Roussin, Anne ^a,b  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b Centre DEvaluation et DInformation sur la Pharmacodpendance   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALIMEMAZINE; ANTACID AGENT; ANTIHISTAMINIC AGENT; CALCIUM CARBONATE; CHLORPHENIRAMINE; CODEINE; DEXTROMETHORPHAN; DIMENHYDRINATE; DOXYLAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; MAGNESIUM CARBONATE; NARCOTIC ANALGESIC AGENT; OXOMEMAZINE; PARACETAMOL; PROMETHAZINE; PSEUDOEPHEDRINE;

ADULT; AGED; ARTICLE; COUGHING; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG ABUSE; DRUG DEPENDENCE; DRUG MISUSE; DRUG OVERDOSE; DRUG SELF ADMINISTRATION; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT PARTICIPATION; PHARMACY; PILOT STUDY; PRIORITY JOURNAL; SEDATION; SELF MEDICATION; SIDE EFFECT; SLEEP DISORDER; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ANTACIDS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NONPRESCRIPTION DRUGS; PHARMACIES; PHARMACOEPIDEMIOLOGY; PILOT PROJECTS; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; SELF MEDICATION; STATISTICS, NONPARAMETRIC; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 69849084934     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11316590-000000000-00000     Document Type: Article

References (39)

1. Le marche de l'automedication en France [online]. Available from URL: http://www.leem.org/htm/themes/article.asp?id-article=437 [Accessed 2008 Dec 18]
2. Bond C, Hannaford P. Issues related to monitoring the safety of over-the-counter (OTC) medicines. Drug Saf 2003; 26 (15): 1065-74
3. Ford C, Good B. Over the counter drugs can be highly addictive. BMJ 2007 May 5; 334 (7600): 917-8
4. Micaleff J, Jolliet P, Victorri-Vigneau C, et al. First meeting of the French CEIP (centres d'evaluation et d'information sur la pharmacodependance): assessment of the abuse and pharmacodependence potential during drug development. Therapie 2008 Jan-Feb; 63 (1): 55-65
5. Boeuf O, Lapeyre-Mestre M, and French Network of Centers for Evaluation and Information Pharmacodepen-dence (CEIP). Survey of forged prescriptions to investigate risk of psychoactive medications abuse in France: results of OSIAP survey. Drug Saf 2007; 30 (3): 265-76
6. Zacny J, Bigelow G, Compton P, et al. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend 2003 Apr 1;69 (3): 215-32
7. NIDA. NIDA InfoFacts: prescription and over-the-counter medications [online]. Available from URL: http://www.nida. nih.gov/infofacts/PainMed.html [Accessed 2008 Dec 18]
8. Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies. Results from the 2001 National Household Survey on Drug Abuse. Vol. II. Technical appendices and selected data tables. Rockville (MD): NHSDA series H-18, DHHS publication no. SMA 02-3759
9. Matheson C, Bond C, Pitcairn J. Misuse of over-the counter medicines from community pharmacies: a population survey of Scottish pharmacies. Pharm J 2002 Jul 13; 269: 66-8
10. Pates R, McBride AJ, Li S, et al. Misuse of over-the counter medicines: a survey of community pharmacies in a South Wales health authority. Pharm J 2002 Feb; 268: 179-82
11. Wazaify M, Shields E, Hughes CM, et al. Societal perspectives on over-the-counter (OTC) medicines. Fam Pract 2005 Apr; 22 (2): 170-6
12. Sinclair HK, Bond CM, Hannaford PC. Pharmacovigilance of over-the-counter products based in community pharmacy: a feasible option? Grampian Pharmacy Network. Pharmacoepidemiol Drug Saf 1999 Dec; 8 (7): 479-91
13. Hasford J, Fagerstrom KO, Haustein KO. A naturalistic cohort study on effectiveness, safety and usage pattern of an over-the-counter nicotine patch: cohort study on smoking cessation. Eur J Clin Pharmacol 2003 Sep; 59 (5-6): 443-7
14. Hasford J, Moore N, Hoye K. Safety and usage pattern of low-dose diclofenac when used as an over-the-counter medication: results of an observational cohort study in a community-based pharmacy setting. Int J Clin Pharmacol Ther 2004 Aug; 42 (8): 415-22
15. Stewart D, Helms P, McCaig D, et al. Monitoring adverse drug reactions in children using community pharmacies: a pilot study. Br J Clin Pharmacol 2005 Jun; 59 (6): 677-83
16. Schulz M, Hammerlein A, Hinkel U, et al. Safety and usage pattern of an over-the-counter ambroxol cough syrup: a community pharmacy-based cohort study. Int J Clin Pharmacol Ther 2006 Sep; 44 (9): 409-21
17. Hinkel U, Schuijt C, Erckenbrecht JF. OTC laxative use of sodium picosulfate: results of a pharmacy-based patient survey (cohort study). Int J Clin Pharmaco Ther 2008 Feb; 46 (2): 89-95
18. Glossaire des vigilances [online]. Available from URL: http://afssaps.sante.fr/pdf/5/glossaire-vigilances.pdf [Accessed 2008 Dec 18]
19. Article R 5132-99 du Code de la sante Publique [online]. Available from URL: http://agmed.sante.gouv.fr/htm/10/pharma/indpharm.htm [Accessed 2008 Dec 18]
20. World Health Organization. International statistical classification of diseases and related health problems. 10th rev. Geneva: World Health Organization, 2007
21. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, text revision. Washington, DC: American Psychiatric Association, 2000
22. Højsted J, Sjøgren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 2007 Jul; 11 (5): 490-518
23. Hughes GF, McElnay JC, Hughes CM, et al. Abuse/misuse of non-prescription drugs. Pharm World Sci 1999 Dec; 21 (6): 251-5
24. Fleming GF, McElnay JC, Hughes CM. Development of a community pharmacy-based model to identify and treat OTC drug abuse/misuse: a pilot study. Pharm World Sci 2004 Oct; 26 (5): 282-8
25. Wazaify M, Hughes CM, McElnay JC. The implementation of a harm minimisation model for the identification and treatment of over-the counter drug misuse and abuse in community pharmacies in Northern Ireland. Patient Educ Couns 2006 Dec; 64 (1-3): 136-41
26. Layton D, Sinclair HK, Bond CM, et al. Pharmacovigilance of over-the-counter products based in community pharmacy: methodological issues from pilot work conducted in Hampshire and Grampian, UK. Pharmacoepidemiol Drug Saf 2002 Sep; 11 (6): 503-13
27. Llau ME, Lapeyre-Mestre M, Plas L, et al. Forged medical prescriptions in a community pharmacy network in Midi-Pyrenees area: assessment of a falsification ratio. Eur J Clin Pharmacol 2002 Feb; 57 (12): 911-2
28. Kalantar JS, Talley NJ. The effects of lottery incentive and length of questionnaire on health survey response rates: a randomized study. J Clin Epidemiol 1999 Nov; 52 (11): 1117-22
29. Bents RT, Marsh E. Patterns of ephedra and other stimulant use in collegiate hockey athletes. Int J Sport Nutr Exerc Metab 2006 Dec; 16 (6): 636-43
30. Eccles R. Substitution of phenylephrine for pseudoephedrine as a nasal decongestant: an illogical way to control methamphetamine abuse. Br J Clin Pharmacol 2007 Jan; 63 (1): 10-4
31. Schwartz RH. Adolescent abuse of dextromethorphan. Clin Pediatr (Phila) 2005 Sep; 44 (7): 565-8
32. Cranston JW, Yoast R. Abuse of dextromethorphan. Arch Fam Med 1999 Mar-Apr; 8 (2): 99-100
33. Olivier P, Marechal K, Llau ME, et al. Use of codeine and non-codeine cough suppressants. Clin Drug Investig 2002; 22 (6): 399-402
34. Armand C, Thirion X, Saillard C, et al. Neocodion misuse: evolution between 1992 and 2002. Therapie 2004 Sep-Oct; 59 (5): 547-53
35. Myers B, Siegfried N, Parry CD. Over-the-counter and prescription medicine misuse in Cape Town: findings from specialist treatment centres. S Afr Med J 2003 May; 93 (5): 367-70
36. Elander J, Lusher J, Bevan D, et al. Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than genuine analgesic dependence. J Pain Symptom Manage 2004 Feb; 27 (2): 156-69
37. Ferrari A, Cicero AF, Bertolini A, et al. Need for analgesics/ drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ). Cephalalgia 2006 Feb; 26 (2): 187-93
38. MacFadyen L, Eadie D, McGowan T. Community pharmacists' experience of over-the-counter medicine misuse in Scotland. J R Soc Health 2001 Sep; 121 (3): 185-92
39. McCarthy M. Prescription drug abuse up sharply in the USA. Lancet 2007 May 5; 369 (9572): 1505-6.